menu
    • menu

    Company profile for Celltrion

    NEW Drugs in Dev: 41
    European CDMO and Gx manufacturer with 75 years of experience in delivering premium APIs to pharmaceutical partners worldwide.

    Virtual Booth

    Contact Supplier

    Minakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.

    Virtual Booth

    Contact Supplier

    USP reference standards; highly characterized specimens of drug substances, impurities, excipients, degradation products & more.

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.

    Virtual Booth

    Contact Supplier

    Guizhou Utide Biotechnology Co., Ltd. - Specialized GMP manufacturing for next-generation GLP-1 peptide APIs.

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Celltrion stands as a prominent player in the Korean pharmaceutical landscape, accomplishing a feat once deemed improbable introducing the world's first "antibody biosimilar" from a nation with a comparatively less developed pharmaceutical sector. The company has boldly ventured into unexplored territories, achieving remarkable success. Building on this momentum, Celltrion is poised to further expand its footprint as a global ...
    Celltrion stands as a prominent player in the Korean pharmaceutical landscape, accomplishing a feat once deemed improbable introducing the world's first "antibody biosimilar" from a nation with a comparatively less developed pharmaceutical sector. The company has boldly ventured into unexplored territories, achieving remarkable success. Building on this momentum, Celltrion is poised to further expand its footprint as a global biopharmaceutical entity, showcasing distinctive strategies in areas like small molecule pharmaceuticals and pioneering ventures such as the Ubiquitous healthcare platform business.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Celltrionkorearepublicofnew Flag
    Country
    Country
    South Korea
    Address
    Address
    Yeonsu-gu, Incheon Metropolitan City
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.celltrion.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/celltrioninc/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/celltriondream?lang=en

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    PBP World Meeting

    Not Confirmed

    envelop Contact Supplier

    PBP World Meeting

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Celltrion Launches AVTOZMA Subcutaneous in U.S
    Celltrion Launches AVTOZMA Subcutaneous in U.S

    16 Mar 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/celltrion-announces-us-availability-of-avtozma-tocilizumab-anoh-subcutaneous-sc-formulation-302712962.html

    PR NEWSWIRE
    16 Mar 2026
    Share Share
    New ECCO Data Show Subcutaneous SC) Infliximab (Remsima™ SC)
    New ECCO Data Show Subcutaneous SC) Infliximab (Remsima™ SC)

    16 Feb 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260204666761/en/New-ECCO-data-show-subcutaneous-SC-infliximab-Remsima-SC-effectively-recaptures-and-maintains-disease-control-after-drug-holiday

    BUSINESSWIRE
    16 Feb 2026
    Share Share
    Celltrion’s Biologics Avtozma Receives Approval in US
    Celltrion’s Biologics Avtozma Receives Approval in US

    21 Jan 2026

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761498

    FDA
    21 Jan 2026
    Share Share
    Celltrion Spotlights Abpro's ABP-102 at 44th JPM Conference
    Celltrion Spotlights Abpro's ABP-102 at 44th JPM Conference

    15 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/15/3219396/0/en/Abpro-s-Lead-Program-ABP-102-Featured-in-Celltrion-Presentation-at-the-44th-Annual-J-P-Morgan-Healthcare-Conference.html

    GLOBENEWSWIRE
    15 Jan 2026
    Share Share
    Celltrion Unveils Pipeline, US R&D Expansion at JPM Conference
    Celltrion Unveils Pipeline, US R&D Expansion at JPM Conference

    13 Jan 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/celltrion-presents-innovative-drug-pipeline-and-us-manufacturing-and-rd-expansion-strategy-at-the-44th-annual-jp-morgan-healthcare-conference-302660477.html

    PR NEWSWIRE
    13 Jan 2026
    Share Share
    Celltrion To Present At 44th J.P. Morgan Healthcare Conference
    Celltrion To Present At 44th J.P. Morgan Healthcare Conference

    06 Jan 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/celltrion-to-present-at-the-44th-annual-jp-morgan-healthcare-conference-302654432.html

    PR NEWSWIRE
    06 Jan 2026
    Share Share

    Inspections and registrations

    Upload your audits for free, ask us

    ABOUT THIS PAGE

    Contact Celltrion and get a quotation

    Celltrion is a supplier offers 3 products (APIs, Excipients or Intermediates).

    Find a price of Infliximab bulk with JDMF offered by Celltrion

    Find a price of Trastuzumab bulk with JDMF offered by Celltrion

    Find a price of Infliximab bulk offered by Celltrion

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search